Cargando…
Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
Renal fibrosis, which is a critical pathophysiological event in chronic kidney diseases, is associated with renal epithelial-to-mesenchymal transition (EMT). Epoxyeicosatrienoic acids (EETs) are Cyp epoxygenase arachidonic acid metabolites that demonstrate biological actions that result in kidney pr...
Autores principales: | Skibba, Melissa, Hye Khan, Md. Abdul, Kolb, Lauren L., Yeboah, Michael M., Falck, John R., Amaradhi, Radhika, Imig, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491687/ https://www.ncbi.nlm.nih.gov/pubmed/28713267 http://dx.doi.org/10.3389/fphar.2017.00406 |
Ejemplares similares
-
Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
por: Hye Khan, Md. Abdul, et al.
Publicado: (2019) -
Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
por: Hye Khan, Md. Abdul, et al.
Publicado: (2014) -
Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats
por: Baranowska, Iwona, et al.
Publicado: (2022) -
Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity
por: Imig, John D., et al.
Publicado: (2021) -
Development of Epoxyeicosatrienoic Acid Analogs with in Vivo Anti-Hypertensive Actions
por: Imig, John D., et al.
Publicado: (2010)